AMRI to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference

AMRI (NASDAQ: AMRI) announced today that it will present and provide an audio webcast of its corporate presentation at the Bank of America and Merrill Lynch 2009 Healthcare Conference in New York City on Wednesday, May 13, 2009.

AMRI Chief Executive Officer Thomas E. D'Ambra will present in a session scheduled for 2:40 p.m. EDT. The audio webcast will be available to investors and interested parties by accessing the company’s website at www.amriglobal.com. In addition, a replay of the webcast will be available three hours after the live webcast through May 29, 2009.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.